Cargando…

Usage of Inhalative Sedative for Sedation and Treatment of Patient with Severe Brain Injury in Germany, a Nationwide Survey

Brain injured patients often need deep sedation to prevent or treat increased intracranial pressure. The mainly used IV sedatives have side effects and/or high context-sensitive half-lives, limiting their use. Inhalative sedatives have comparatively minor side effects and a brief context-sensitive h...

Descripción completa

Detalles Bibliográficos
Autores principales: Roggenbuck, Svea Roxana, Worm, André, Juenemann, Martin, Claudi, Christian, Alhaj Omar, Omar, Tschernatsch, Marlene, Huttner, Hagen B., Schramm, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573088/
https://www.ncbi.nlm.nih.gov/pubmed/37835045
http://dx.doi.org/10.3390/jcm12196401
_version_ 1785120383946457088
author Roggenbuck, Svea Roxana
Worm, André
Juenemann, Martin
Claudi, Christian
Alhaj Omar, Omar
Tschernatsch, Marlene
Huttner, Hagen B.
Schramm, Patrick
author_facet Roggenbuck, Svea Roxana
Worm, André
Juenemann, Martin
Claudi, Christian
Alhaj Omar, Omar
Tschernatsch, Marlene
Huttner, Hagen B.
Schramm, Patrick
author_sort Roggenbuck, Svea Roxana
collection PubMed
description Brain injured patients often need deep sedation to prevent or treat increased intracranial pressure. The mainly used IV sedatives have side effects and/or high context-sensitive half-lives, limiting their use. Inhalative sedatives have comparatively minor side effects and a brief context-sensitive half-life. Despite the theoretical advantages, evidence in this patient group is lacking. A Germany-wide survey with 21 questions was conducted to find out how widespread the use of inhaled sedation is. An invitation for the survey was sent to 226 leaders of intensive care units (ICU) treating patients with brain injury as listed by the German Society for Neurointensive Care. Eighty-nine participants answered the questionnaire, but not all items were responded to, which resulted in different absolute counts. Most of them (88%) were university or high-level hospital ICU leaders and (67%) were leaders of specialized neuro-ICUs. Of these, 53/81 (65%) use inhalative sedation, and of the remaining 28, 17 reported interest in using this kind of sedation. Isoflurane is used by 43/53 (81%), sevoflurane by 15/53 (28%), and desflurane by 2. Hypotension and mydriasis are the most common reported side effects (25%). The presented survey showed that inhalative sedatives were used in a significant number of intensive care units in Germany to treat severely brain-injured patients.
format Online
Article
Text
id pubmed-10573088
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105730882023-10-14 Usage of Inhalative Sedative for Sedation and Treatment of Patient with Severe Brain Injury in Germany, a Nationwide Survey Roggenbuck, Svea Roxana Worm, André Juenemann, Martin Claudi, Christian Alhaj Omar, Omar Tschernatsch, Marlene Huttner, Hagen B. Schramm, Patrick J Clin Med Article Brain injured patients often need deep sedation to prevent or treat increased intracranial pressure. The mainly used IV sedatives have side effects and/or high context-sensitive half-lives, limiting their use. Inhalative sedatives have comparatively minor side effects and a brief context-sensitive half-life. Despite the theoretical advantages, evidence in this patient group is lacking. A Germany-wide survey with 21 questions was conducted to find out how widespread the use of inhaled sedation is. An invitation for the survey was sent to 226 leaders of intensive care units (ICU) treating patients with brain injury as listed by the German Society for Neurointensive Care. Eighty-nine participants answered the questionnaire, but not all items were responded to, which resulted in different absolute counts. Most of them (88%) were university or high-level hospital ICU leaders and (67%) were leaders of specialized neuro-ICUs. Of these, 53/81 (65%) use inhalative sedation, and of the remaining 28, 17 reported interest in using this kind of sedation. Isoflurane is used by 43/53 (81%), sevoflurane by 15/53 (28%), and desflurane by 2. Hypotension and mydriasis are the most common reported side effects (25%). The presented survey showed that inhalative sedatives were used in a significant number of intensive care units in Germany to treat severely brain-injured patients. MDPI 2023-10-08 /pmc/articles/PMC10573088/ /pubmed/37835045 http://dx.doi.org/10.3390/jcm12196401 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Roggenbuck, Svea Roxana
Worm, André
Juenemann, Martin
Claudi, Christian
Alhaj Omar, Omar
Tschernatsch, Marlene
Huttner, Hagen B.
Schramm, Patrick
Usage of Inhalative Sedative for Sedation and Treatment of Patient with Severe Brain Injury in Germany, a Nationwide Survey
title Usage of Inhalative Sedative for Sedation and Treatment of Patient with Severe Brain Injury in Germany, a Nationwide Survey
title_full Usage of Inhalative Sedative for Sedation and Treatment of Patient with Severe Brain Injury in Germany, a Nationwide Survey
title_fullStr Usage of Inhalative Sedative for Sedation and Treatment of Patient with Severe Brain Injury in Germany, a Nationwide Survey
title_full_unstemmed Usage of Inhalative Sedative for Sedation and Treatment of Patient with Severe Brain Injury in Germany, a Nationwide Survey
title_short Usage of Inhalative Sedative for Sedation and Treatment of Patient with Severe Brain Injury in Germany, a Nationwide Survey
title_sort usage of inhalative sedative for sedation and treatment of patient with severe brain injury in germany, a nationwide survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573088/
https://www.ncbi.nlm.nih.gov/pubmed/37835045
http://dx.doi.org/10.3390/jcm12196401
work_keys_str_mv AT roggenbucksvearoxana usageofinhalativesedativeforsedationandtreatmentofpatientwithseverebraininjuryingermanyanationwidesurvey
AT wormandre usageofinhalativesedativeforsedationandtreatmentofpatientwithseverebraininjuryingermanyanationwidesurvey
AT juenemannmartin usageofinhalativesedativeforsedationandtreatmentofpatientwithseverebraininjuryingermanyanationwidesurvey
AT claudichristian usageofinhalativesedativeforsedationandtreatmentofpatientwithseverebraininjuryingermanyanationwidesurvey
AT alhajomaromar usageofinhalativesedativeforsedationandtreatmentofpatientwithseverebraininjuryingermanyanationwidesurvey
AT tschernatschmarlene usageofinhalativesedativeforsedationandtreatmentofpatientwithseverebraininjuryingermanyanationwidesurvey
AT huttnerhagenb usageofinhalativesedativeforsedationandtreatmentofpatientwithseverebraininjuryingermanyanationwidesurvey
AT schrammpatrick usageofinhalativesedativeforsedationandtreatmentofpatientwithseverebraininjuryingermanyanationwidesurvey